Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MF-DH-300 | 2673403-86-4 | 99.5% | 330.38 | 10 MG
SDP

Catalog No. 5000365142
Encompass_Preferred

MF-DH-300 is a 15-PGDH inhibitor used for research into muscle disorders such as spinal muscular atrophy (SMA). It targets 15-PGDH (15-Hydroxyprostaglandin dehydrogenase), an enzyme that acts as a tumor suppressor in various organs. By metabolizing intracellular PGE2, this compound suppresses PGE2 signaling, which is implicated in tumorigenesis.

  • Used for research into muscle disorders
  • Inhibits 15-PGDH
  • Acts as a tumor suppressor
  • Metabolizes intracellular PGE2
  • Suppresses PGE2 signaling
  • Applicable to spinal muscular atrophy (SMA) research

Catalog No. 50-003-65142 Supplier Medchemexpress LLC Supplier No. 10MGHY176803
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MF-DH-300 is a 15-PGDH inhibitor used for research into muscle disorders such as spinal muscular atrophy (SMA). It targets 15-PGDH (15-Hydroxyprostaglandin dehydrogenase), an enzyme that acts as a tumor suppressor in various organs. By metabolizing intracellular PGE2, this compound suppresses PGE2 signaling, which is implicated in tumorigenesis.

  • Used for research into muscle disorders
  • Inhibits 15-PGDH
  • Acts as a tumor suppressor
  • Metabolizes intracellular PGE2
  • Suppresses PGE2 signaling
  • Applicable to spinal muscular atrophy (SMA) research

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.